| Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community C Vitali, S Bombardieri, HM Moutsopoulos, G Balestrieri, W Bencivelli, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1993 | 1890 | 1993 |
| Epidemiology of adult rheumatoid arthritis Y Alamanos, AA Drosos Autoimmunity reviews 4 (3), 130-136, 2005 | 1430 | 2005 |
| Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review Y Alamanos, PV Voulgari, AA Drosos Seminars in arthritis and rheumatism 36 (3), 182-188, 2006 | 1121 | 2006 |
| Physical inactivity in patients with rheumatoid arthritis: data from twenty‐one countries in a cross‐sectional, international study T Sokka, A Häkkinen, H Kautiainen, JF Maillefert, S Toloza, ... Arthritis Care & Research: Official Journal of the American College of …, 2008 | 443 | 2008 |
| European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity … G Valentini, A Della Rossa, S Bombardieri, W Bencivelli, AJ Silman, ... Annals of the rheumatic diseases 60 (6), 592-598, 2001 | 441 | 2001 |
| Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment–a prospective, controlled study AN Georgiadis, EC Papavasiliou, ES Lourida, Y Alamanos, C Kostara, ... Arthritis research & therapy 8, 1-7, 2006 | 369 | 2006 |
| Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis DN Kiortsis, AK Mavridis, S Vasakos, SN Nikas, AA Drosos Annals of the rheumatic diseases 64 (5), 765-766, 2005 | 327 | 2005 |
| Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982–2003 Y Alamanos, N Tsifetaki, PV Voulgari, AI Venetsanopoulou, C Siozos, ... Rheumatology 45 (2), 187-191, 2006 | 309 | 2006 |
| Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide JPA Ioannidis, KA Boki, ME Katsorida, AA Drosos, FN Skopouli, ... Kidney international 57 (1), 258-264, 2000 | 271 | 2000 |
| Incidence and prevalence of psoriatic arthritis: a systematic review Y Alamanos, PV Voulgari, AA Drosos The Journal of rheumatology 35 (7), 1354-1358, 2008 | 243 | 2008 |
| Outcome of lupus pregnancy: a controlled study PE Georgiou, EN Politi, P Katsimbri, V Sakka, AA Drosos Rheumatology 39 (9), 1014-1019, 2000 | 236 | 2000 |
| A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease D Daoussis, K Melissaropoulos, G Sakellaropoulos, I Antonopoulos, ... Seminars in arthritis and rheumatism 46 (5), 625-631, 2017 | 233 | 2017 |
| Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis PV Voulgari, G Kolios, GK Papadopoulos, A Katsaraki, K Seferiadis, ... Clinical Immunology 92 (2), 153-160, 1999 | 221 | 1999 |
| Remission and rheumatoid arthritis: data on patients receiving usual care in twenty‐four countries T Sokka, ML Hetland, H Mäkinen, H Kautiainen, K Hørslev‐Petersen, ... Arthritis & Rheumatism 58 (9), 2642-2651, 2008 | 220 | 2008 |
| Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST–RA database T Sokka, H Kautiainen, T Pincus, S Toloza, GRC Pinheiro, J Lazovskis, ... Annals of the rheumatic diseases 68 (11), 1666-1672, 2009 | 218 | 2009 |
| Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? NG Papadopoulos, Y Alamanos, PV Voulgari, EK Epagelis, N Tsifetaki, ... Clinical and experimental rheumatology 23 (6), 861, 2005 | 214 | 2005 |
| Primary Sjögren syndrome in the paediatric age: a multicentre survey R Cimaz, A Casadei, C Rose, J Bartunkova, A Sediva, F Falcini, P Picco, ... European journal of pediatrics 162, 661-665, 2003 | 207 | 2003 |
| Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren’s syndrome: a randomised 12 week controlled study N Tsifetaki, G Kitsos, CA Paschides, Y Alamanos, V Eftaxias, PV Voulgari, ... Annals of the rheumatic diseases 62 (12), 1204-1207, 2003 | 205 | 2003 |
| Demyelination and other neurological adverse events after anti-TNF therapy E Kaltsonoudis, PV Voulgari, S Konitsiotis, AA Drosos Autoimmunity reviews 13 (1), 54-58, 2014 | 192 | 2014 |
| The spectrum of neurological involvement in Sjögren's syndrome AP Andonopoulos, G Lagos, AA Drosos, HM Moutsopoulos Rheumatology 29 (1), 21-24, 1990 | 175 | 1990 |
